Meeting
2023 ASCO Annual Meeting
LungFlag, a machine-learning (ML) personalized tool for assessing lung cancer risk in a community setting, to evaluate performance in flagging non-small cell lung cancer (NSCLC) regardless of sex or race.
Authors
David Morgenstern
Roche Diagnostics, Indianapolis, IN
David Morgenstern , Eran Netanel Choman
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Prevention, Risk Reduction, and Hereditary Cancer
Track
Prevention, Risk Reduction, and Genetics
Sub Track
Cancer Prevention
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 10570)
DOI
10.1200/JCO.2023.41.16_suppl.10570
Abstract #
10570
Poster Bd #
203
Abstract Disclosures
Similar Posters
Poster
2021 ASCO Quality Care Symposium
Machine learning-based approach to the risk assessment of potentially preventable outpatient cancer treatment-related emergency care and hospitalizations.
First Author: Kevin Miao
Poster
2024 ASCO Breakthrough
Precision medicine-based platform to guide the treatment of EML4-ALK driven lung cancers and other NSCLC in real time.
First Author: Sofia Diana Merajver
Poster
2024 ASCO Annual Meeting
Budget impact model of LungFlag, a predictive risk model for lung cancer screening.
First Author: Michael K. Gould
Poster
2024 ASCO Annual Meeting
Artificial intelligence-based prediction model of malignant lung nodules for preoperative planning.
First Author: Di Lu